Market cap
$33 Mln
Revenue (TTM)
$22 Mln
P/E Ratio
17.9
P/B Ratio
2.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -6.56 | 18.01 | 20.36 | 16.80 | 16.83 |
| EBIT | -57.79 | 50.59 | 23.66 | 46.43 | 20.94 |
| Net Profit | -57.23 | 51.93 | 29.03 | 44.24 | -18.37 |
| EPS | -57.58 | 49.72 | 24.44 | 43.64 | 19.51 |
| Book Value | -- | -- | 14.37 | 19.65 | -7.66 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -1.33 | -14.70 | 8.65 | 6.42 | 0.64 |
| Net Margin
| -- | -- | 8.86 | -- | -- |
| Return on equity
| -3.00 | -25.66 | 16.44 | 12.71 | 0.87 |
| Return on Capital
| -2.23 | -22.57 | -- | 11.23 | 0.73 |
| Return on Assets
| -1.18 | -15.56 | 11.43 | 9.61 | 0.64 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.10 | 0.16 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
--
|
11.23
|
0.73
|
-18.66
|
-76.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
16.44
Lower than Peers by 1.78
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
16.44
|
12.71
|
0.87
|
-22.58
|
-85.41
|
|
Peer Median
|
18.22
|
--
|
--
|
--
|
--
|
ROA
11.43
Higher than Peers by 5.70
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
11.43
|
9.61
|
0.64
|
-13.78
|
-51.53
|
|
Peer Median
|
5.73
|
--
|
--
|
--
|
--
|
EBIT Margin
8.65
Lower than Peers by 5.71
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
8.65
|
6.42
|
0.64
|
-11.05
|
-42.68
|
|
Peer Median
|
14.36
|
--
|
--
|
--
|
--
|
Net Margin
8.86
Lower than Peers by 1.39
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
8.86
|
6.35
|
0.52
|
-11.06
|
-74.01
|
|
Peer Median
|
10.25
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
20.36
Higher than Peers by 14.23
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
20.36
|
0.33
|
-0.01
|
0.43
|
-0.02
|
|
Peer Median
|
6.13
|
--
|
--
|
--
|
--
|
EBIT Growth
23.66
Higher than Peers by 19.52
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
23.66
|
1,241.11
|
105.72
|
63.05
|
-55.20
|
|
Peer Median
|
4.14
|
--
|
--
|
--
|
--
|
Net Profit Growth
29.03
Higher than Peers by 24.18
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
29.03
|
1,513.51
|
104.70
|
78.66
|
-79.74
|
|
Peer Median
|
4.85
|
--
|
--
|
--
|
--
|
EPS Growth
24.44
Higher than Peers by 16.80
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
24.44
|
14.53
|
1.05
|
0.79
|
-0.75
|
|
Peer Median
|
7.64
|
--
|
--
|
--
|
--
|
Book Value Growth
23.58
Higher than Peers by 13.34
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
23.58
|
--
|
--
|
--
|
--
|
|
Peer Median
|
10.24
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
--
|
0.10
|
0.16
|
0.22
|
0.20
|
|
Peer Median
|
1.02
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.03
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
0.03
|
0.04
|
0.04
|
0.05
|
0.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
5.50
Higher than Peers by 4.12
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
5.50
|
4.06
|
5.31
|
3.98
|
5.85
|
|
Peer Median
|
1.38
|
--
|
--
|
--
|
--
|
Quick Ratio
3.45
Higher than Peers by 2.25
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
3.45
|
2.89
|
3.64
|
2.81
|
3.62
|
|
Peer Median
|
1.20
|
--
|
--
|
--
|
--
|
Interest Coverage
642.33
Higher than Peers by 636.93
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
642.33
|
1,207.00
|
90.00
|
-786.50
|
-212.85
|
|
Peer Median
|
5.40
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
16.60
Higher than Peers by 0.40
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
16.60
|
12.85
|
12.58
|
10.51
|
12.89
|
|
Peer Median
|
16.21
|
--
|
--
|
--
|
--
|
Asset Turnover
1.29
Higher than Peers by 0.75
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
1.29
|
1.51
|
1.23
|
1.25
|
0.70
|
|
Peer Median
|
0.55
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
--
|
40.77
|
42.26
|
35.68
|
53.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
--
|
146.20
|
170.74
|
176.05
|
265.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
--
|
39.08
|
51.10
|
50.50
|
72.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
--
|
147.89
|
161.89
|
161.23
|
246.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
17.94
Lower than Peers by 11.53
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
17.94
|
44.83
|
209.69
|
-23.16
|
-1.61
|
|
Peer Median
|
29.47
|
--
|
--
|
--
|
--
|
Price / Book Value
2.87
Lower than Peers by 2.84
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
2.87
|
5.25
|
1.81
|
4.36
|
2.13
|
|
Peer Median
|
5.71
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1.02
|
--
|
--
|
--
|
--
|
EV/EBITDA
15.76
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
15.76
|
36.54
|
58.01
|
-25.03
|
-2.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
33
Lower than Peers by 1,516
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Nephros (NEPH)
|
33
|
--
|
--
|
--
|
--
|
|
Peer Median
|
1,549
|
--
|
--
|
--
|
--
|